Cost-effectiveness of azacitidine and ivosidenib in newly diagnosed older, intensive chemotherapy-ineligible patients with IDH1-mutant acute myeloid leukemia
- Resource Type
- Source
- Leukemia & Lymphoma. 64:454-461
- Subject
Cancer Research Oncology Hematology - Language
- ISSN
- 1029-2403
1042-8194